Due to the lack of proven efficacy and safety concerns, laetrile is not approved by the FDA for cancer treatment or any other medical use. It is considered an unapproved drug, and its sale and distribution are restricted in the United States and many other countries. Despite these restrictions, laetrile is still available in some regions, often marketed as a dietary supplement or sold online under the guise of "vitamin B17."
